Cooperative antitumor effect of endothelial-monocyte activating polypeptide II and flutamide on human prostate cancer xenografts

• Published in: Experimental Oncology
• Date: 2011
• Main Authors: Reznikov, A.G., Chaykovskaya, L.V., Polyakova, L.I., Kornelyuk, A.I., Grygorenko, V.N.
• Format: Article
• Language: English
• Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2011
• Subjects: Original contributions
• Online Access: https://nasplib.isofts.kiev.ua/handle/123456789/138678
• Journal Title: Digital Library of Periodicals of National Academy of Sciences of Ukraine
• Cite this: Cooperative antitumor effect of endothelial-monocyte activating polypeptide II and flutamide on human prostate cancer xenografts / A.G. Reznikov, L.V. Chaykovskaya, L.I. Polyakova, A.I. Kornelyuk, V.N. Grygorenko // Experimental Oncology. — 2011. — Т. 33, № 4. — С. 231-234. — Бібліогр.: 23 назв. — англ.

Recombinant cytokine-like endothelial monocyte-activating polypeptide II (EMAP II) and antiandrogen flutamide target different mechanisms of growth of androgen-dependent prostate cancer (PC). The aim of this study was to clarify whether combined treatment with EMAP II and flutamide is more effective...